August 2012 in “ScholarSpace (University of Hawaii at Manoa)” Certain symptoms can help predict iron deficiency in college-age individuals.
1 citations
,
December 2020 in “Medicinskij alfavit” Telogen effluvium is a condition that causes temporary hair loss.
2 citations
,
August 2025 in “Scientific Reports” Pexidartinib often causes liver issues and fatigue, especially in women.
39 citations
,
March 2022 in “Infection” Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.
18 citations
,
August 2011 in “Medical Hypotheses” Physical inactivity is a primary cause of many human illnesses.
19 citations
,
June 2001 in “Annals of Internal Medicine” Tamoxifen can cause total hair loss but its benefits outweigh this side effect.
June 2023 in “GALENICAL Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh” Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
January 2025 in “BMC Nephrology” Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.
15 citations
,
October 2016 in “PubMed” People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.
2 citations
,
January 2012 in “Hair therapy & transplantation” Low serum ferritin levels are not closely linked to telogen effluvium in women.
21 citations
,
January 1988 in “Critical Care Medicine” Critically ill patients may experience temporary hair loss after a fever.
12 citations
,
January 2017 in “PubMed” Gastroparesis can cause persistent TSH elevation in hypothyroidism despite treatment.
3 citations
,
August 2020 in “Cutaneous and Ocular Toxicology” ATP helps prevent skin damage from vandetanib by reducing stress.
3 citations
,
January 2019 in “Annals of medical research” The conclusion cannot be provided because the document content is not available.
July 2025 in “Dermatology and Therapy” Patients with fewer past treatments for alopecia areata respond better to baricitinib.
January 2024 in “Medicine” Hypothyroidism is often linked to the hair loss condition telogen effluvium.
2 citations
,
April 2022 in “Sleep and Breathing” 15 citations
,
December 2000 in “Der Hautarzt” Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.
1 citations
,
April 2021 in “International Journal of Research in Dermatology” Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.
October 2024 in “Journal of the Endocrine Society” Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.
2 citations
,
August 2016 in “kufa journal for nursing sciences” Many elderly in geriatric homes are overweight and need better nutrition management and education.
2 citations
,
July 2025 in “Journal of Health Population and Nutrition” Improving diet may help manage sleep disorders.
11 citations
,
January 2011 in “Turkish Journal of Medical Sciences” Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.
7 citations
,
January 2015 in “Journal of the European Academy of Dermatology and Venereology” Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.
January 1993 in “Journal of Dermatological Treatment” Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.
August 2018 in “Journal of the American Academy of Dermatology” Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.
10 citations
,
October 2016 in “Epilepsy & behavior” Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.
141 citations
,
September 2016 in “European Journal of Dermatology” Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.
December 2025 in “Biomedicines” Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.
April 2025 in “African Journal of Biomedical Research” Breast cancer patients undergoing chemotherapy often worry, lose weight, and cope by praying, meditating, or seeking support.